SHANGHAI SANYOU MEDICAL CO., LTD Financials Shanghai Sanyou Medical Co., Ltd
Equities
688085
CNE1000040J7
Medical Equipment, Supplies & Distribution
|
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 18 CNY | -4.31% |
|
+0.67% | -7.69% |
| May. 09 | Shanghai Sanyou Medical's French Unit Gets Nod to Market Jazz Spinal System in US; Shares Up 3% | MT |
| May. 08 | Shanghai Sanyou Medical Gets Registration Certificate for Peek Medical Product | MT |
Valuation
| Fiscal Period: December | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|
| Capitalization 1 | 7,959 | 6,339 | 6,268 | 4,845 | 4,472 | - |
| Enterprise Value (EV) 1 | 7,959 | 6,339 | 6,268 | 4,845 | 4,472 | 4,472 |
| P/E ratio | 61.5 x | 33.9 x | 33 x | 52.7 x | 34 x | 19.9 x |
| Yield | 0.45% | 0.59% | - | - | - | - |
| Capitalization / Revenue | 20.4 x | 10.7 x | 9.66 x | 10.5 x | 7.39 x | 4.87 x |
| EV / Revenue | 20.4 x | 10.7 x | 9.66 x | 10.5 x | 7.39 x | 4.87 x |
| EV / EBITDA | 53.1 x | 27.6 x | 24.1 x | 28.4 x | 19.4 x | 13.5 x |
| EV / FCF | - | - | - | - | - | - |
| FCF Yield | - | - | - | - | - | - |
| Price to Book | 5.19 x | 3.76 x | 3.41 x | 2.54 x | 2.18 x | 1.97 x |
| Nbr of stocks (in thousands) | 248,454 | 248,454 | 248,454 | 248,454 | 248,454 | - |
| Reference price 2 | 32.03 | 25.51 | 25.23 | 19.50 | 18.00 | 18.00 |
| Announcement Date | 2/2/21 | 2/21/22 | 2/21/23 | 2/23/24 | - | - |
1CNY in Million2CNY
Estimates
Income Statement Evolution (Annual data)
| Fiscal Period: December | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|
| Net sales 1 | 390.4 | 593.4 | 649.2 | 460.7 | 605 | 917.7 |
| EBITDA 1 | 149.8 | 229.9 | 259.7 | 170.6 | 231 | 330.7 |
| EBIT 1 | 130.4 | 204 | 229.1 | 117.3 | 155 | 263.1 |
| Operating Margin | 33.39% | 34.38% | 35.29% | 25.47% | 25.62% | 28.67% |
| Earnings before Tax (EBT) 1 | 136.9 | 217.3 | 239.5 | 63.8 | 185 | 285.5 |
| Net income 1 | 118.6 | 186.4 | 190.8 | 129.9 | 131 | 225.3 |
| Net margin | 30.37% | 31.41% | 29.39% | 28.2% | 21.65% | 24.55% |
| EPS 2 | 0.5207 | 0.7521 | 0.7636 | 0.3700 | 0.5300 | 0.9050 |
| Free Cash Flow | - | - | - | - | - | - |
| FCF margin | - | - | - | - | - | - |
| FCF Conversion (EBITDA) | - | - | - | - | - | - |
| FCF Conversion (Net income) | - | - | - | - | - | - |
| Dividend per Share | 0.1438 | 0.1504 | - | - | - | - |
| Announcement Date | 2/2/21 | 2/21/22 | 2/21/23 | 2/23/24 | - | - |
1CNY in Million2CNY
Estimates
Balance Sheet Analysis
| Fiscal Period: December | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|
| Net Debt | - | - | - | - | - | - |
| Net Cash position | - | - | - | - | - | - |
| Leverage (Debt/EBITDA) | - | - | - | - | - | - |
| Free Cash Flow | - | - | - | - | - | - |
| ROE (net income / shareholders' equity) | 10.3% | 11.6% | 10.8% | 4.87% | 5.9% | 9.55% |
| ROA (Net income/ Total Assets) | - | - | - | - | - | - |
| Assets 1 | - | - | - | - | - | - |
| Book Value Per Share 2 | 6.170 | 6.790 | 7.400 | 7.690 | 8.240 | 9.120 |
| Cash Flow per Share 2 | 0.3100 | 0.5800 | 0.6300 | 1.080 | 0.6500 | 1.000 |
| Capex 1 | 30.5 | 91.3 | 138 | 25.8 | 510 | 478 |
| Capex / Sales | 7.8% | 15.39% | 21.29% | 5.6% | 84.3% | 52.09% |
| Announcement Date | 2/2/21 | 2/21/22 | 2/21/23 | 2/23/24 | - | - |
1CNY in Million2CNY
Estimates
EPS & Dividend
Year-on-year evolution of the PER
Change in Enterprise Value/EBITDA
Trading Rating
Investor Rating
ESG Refinitiv
Sell
Buy
Mean consensus
BUY
Number of Analysts
2
Last Close Price
18
Average target price
-
EPS Revisions
Annual profits - Rate of surprise
| 1st Jan change | Capi. | |
|---|---|---|
| -7.69% | 618M | |
| +75.28% | 12.54B | |
| -20.90% | 7.71B | |
| +8.01% | 6.72B | |
| +12.49% | 5.38B | |
| +37.02% | 4.89B | |
| -17.65% | 4.71B | |
| -25.08% | 3.75B | |
| -26.57% | 2.77B | |
| +58.74% | 2.55B |
- Stock Market
- Equities
- 688085 Stock
- Financials Shanghai Sanyou Medical Co., Ltd
